An interventional study of APA managed by qualified instructor and Autonomous APA in Alcohol Use Disorder, sponsored by Centre Hospitalier Universitaire de Besancon. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-02-12.
Sponsored by Centre Hospitalier Universitaire de Besancon · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 94 studies in Alcoholism with a site in France — 24 open to participants now, 25 under way, 1 of them phase 3. Alcoholism · France.
Among the 94 studies in Alcoholism with a site in France, this one is the 51st largest by planned enrollment of the 58 interventional ones that give a count, is one of 8 that started in 2024, is one of 42 with no phase, reaches primary completion later than 13 of the 24 other live ones, and was the 80th registered.
1,679 studies on the registry are indexed under Alcoholism; 333 are open to participants now.
Browse Alcoholism studies →24 of the 94 studies in Alcoholism with a site in France are open now. Recruiting first, the newest first:
Institut National de la Santé Et de la Recherche Médicale, France · Sites in France
Ages 18–65
Hospices Civils de Lyon · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
CHU de Reims · Sites in France
Ages 18–65 · Healthy volunteers
Centre Hospitalier Régional d'Orléans · Sites in France
Ages 18+ · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 238 Alcoholism studies recruiting now, 85 (36%) set no upper age limit and 131 (55%) stop at 75 or younger; 9 take children under 18; 64 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
94 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 8 · Phase 4 2
First in 2002; this study’s year is marked. 8 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 88 across 1,433 interventional studies indexed under Alcoholism.
Median enrollment 153 across the 58 interventional studies, 113 across the 36 observational. Of the 59 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 94 have an industry lead sponsor. The 10 most frequent:
Centre Hospitalier Universitaire de Besancon is the lead sponsor of 450 studies on the registry; 97 are open to participants now.
Centre Hospitalier Universitaire de Besancon has 1 study filed under Alcoholism — fewer than ten, so there is no comparison to draw.
5 of the studies in Alcoholism with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07369245Versailles HospitalTechniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction | 2027-07-15 |
| NCT04773691Centre Hospitalier Universitaire DijonEffectiveness of High-frequency rTMS in Reducing Alcohol Consumption in Non-abstinent Patients With an Alcohol Use Disorder | 2027-08 |
| NCT06706349Centre Hospitalier Universitaire de BesanconEffect of Adapted Physical Activity on Sleep Quality in People With Alcohol Use Disorder | 2027-10 |
| NCT06675539Etablissement Public de Santé Barthélemy DurandValidation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS) | 2027-10 |
| NCT07844720Institut National de la Santé Et de la Recherche Médicale, FranceStudy on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder | 2027-10-22 |
Add all 5 to your calendar (.ics) → With an account.
Among the 94 studies in Alcoholism with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This feasibility study aims to assess interest, recruitment, and adherence to a supervised physical activity (APA) program among individuals with Alcohol Use Disorder (AUD). It also investigates the program's impact on sleep quality and efficiency. Key objectives include evaluating recruitment feasibility, assessing randomization acceptance, quantifying adherence rates, and identifying sensitive sleep assessment tools. The study will explore whether APA improves sleep outcomes in AUD patients with sleep complaints, laying groundwork for larger-scale research.
Participants will engage in APA sessions, complete sleep assessments (including sleep diaries and psychometric scales), and provide sociodemographic data and past activity adherence.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Signed automobile safety contract:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 3 weekly sessions of supervised adapted physical activity (APA) starting from Visit 3.
Behavioral: APA managed by qualified instructor
Participants in this arm will receive a leaflet summarizing WHO recommendations on physical activity at the start of the study.
Behavioral: Autonomous APA
Each session will be led by a qualified APA professional and will include a mix of aerobic, anaerobic, and 'mind-body' activities like yoga, tailored to participant preferences. Intensity will range from moderate to vigorous, with activities such as walking, cycling, and club-based exercises for at least 20 minutes per session. Participants will be progressively involved in session planning to support continued practice post-study. Heart rate monitoring will be used during exercises like the 6-minute walk test and chair rise test, while a daily activity calendar will help ensure adherence, documenting session dates, durations, subjective intensity, and activity type.
A leaflet highlighting the importance of non-sedentary behavior according to WHO recommendations will be provided to them. They will have the opportunity to engage in physical activity autonomously according to their preference.
Sleep duration measured by actigraphy.
Objective measurement of sleep duration (in minutes) using actigraphy over the course of the study.
Time frame: Baseline, 6 weeks (midpoint), 12 weeks (end of sessions), and 14 weeks (2 weeks post-intervention)
Circadian parameters measured by urinary melatonin levels.
Levels of urinary melatonin (in ng/mL) assessed as an indicator of circadian rhythm.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks
Sleep quality assessed by Pittsburgh Sleep Quality Index (PSQI).
Subjective sleep quality measured using the PSQI, a validated scale ranging from 0 (better quality) to 21 (poor quality).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Insomnia severity measured by Insomnia Severity Index (ISI).
Evaluation of insomnia severity using ISI, a composite scale ranging from 0 (no clinically significant insomnia) to 28 (severe insomnia).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Daytime sleepiness assessed by Epworth Sleepiness Scale (ESS).
Subjective evaluation of daytime sleepiness using ESS, ranging from 0 (no sleepiness) to 24 (severe sleepiness).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Sleep-wake patterns measured by sleep diary.
Participant-reported data on sleep duration and quality using a daily sleep diary.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Morningness-eveningness preferences measured by Horne and Östberg Scale.
Chronotype assessment using the Horne and Östberg Scale, providing a score categorizing participants as morning, intermediate, or evening types.
Time frame: Baseline only.
Adherence to treatment measured by completed APA sessions.
Number of physical activity sessions completed by participants over the course of the study.
Time frame: 12 weeks.
Sociodemographic characteristics collected at baseline.
Collection of sociodemographic data including age, gender, marital status, education level, and employment status.
Time frame: Baseline only.
Previous adherence to physical activity.
Participants' history of engagement in structured physical activity (binary: Yes/No).
Time frame: Baseline only.
Dropout rate during intervention.
Proportion of participants who prematurely discontinued the study intervention.
Time frame: 12 weeks.
Impact of personality traits on treatment adherence.
Analysis of the relationship between personality traits (assessed by validated scales) and adherence to intervention protocols.
Time frame: Baseline to 12 weeks.
Alcohol Consumption
Daily alcohol consumption reported in standard units (equivalent to 10g of alcohol) using the Timeline Follow Back (TLFB) method.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Direct Markers of Alcohol Use
Biological markers directly indicating alcohol consumption.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Indirect Markers of Alcohol Use
Biological markers indirectly indicating alcohol consumption.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Alcohol Dependence (ADS-Fr Score)
Alcohol dependence evaluated using the French version of the Alcohol Dependence Scale (ADS-Fr).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Alcohol Craving (OCDS Score)
Craving for alcohol assessed using the Obsessive-Compulsive Drinking Scale (OCDS)
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Alcohol Craving (VAS Score)
Craving for alcohol assessed using Visual Analog Scales (VAS).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Impact of Craving Profile on Treatment Outcome
Influence of the craving profile on treatment success analyzed using predefined criteria.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Risk of Transition to Compulsive Exercise (EDS-R Score)
Risk of developing compulsive exercise behaviors evaluated using the Exercise Dependence Scale-Revised (EDS-R).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Physical Capacity (Chair Stand Test)
Functional capacity assessed using the Chair Stand Test.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Physical Capacity (6-Minute Walk Test)
Functional capacity assessed using the 6-Minute Walk Test (6MWT).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Physical Activity Level (GPAQ Score)
Physical activity level measured using the Global Physical Activity Questionnaire (GPAQ).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Physical Activity Level (Physical Activity Calendar)
Physical activity patterns documented using a dedicated physical activity calendar.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Body Mass Index (BMI)
Calculated as weight in kilograms divided by the square of height in meters (kg/m²).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Waist Circumference (WC)
Measurement of waist circumference in centimeters.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Thigh Circumference (TC)
Measurement of thigh circumference in centimeters.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Blood Pressure (BP)
Systolic and diastolic blood pressure measured in millimeters of mercury (mmHg).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Pulse Rate
Pulse rate measured in beats per minute (bpm).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Depression (QIDS Score)
Depression severity assessed using the Quick Inventory of Depressive Symptomatology (QIDS).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Anxiety (STAI Score)
Anxiety levels evaluated using the State-Trait Anxiety Inventory (STAI).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Impulsivity (UPPS-P Score)
Impulsive behaviors assessed using the UPPS-P Impulsive Behavior Scale.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Self-Esteem (Rosenberg Score)
Self-esteem assessed using the Rosenberg Self-Esteem Scale.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Quality of Life (WHOQOL-BREF Score)
Quality of life assessed using the WHO Quality of Life-BREF (WHOQOL-BREF) questionnaire.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Decision-Making Abilities (MCQ-27 Score)
Decision-making abilities assessed using the Monetary Choice Questionnaire (MCQ-27).
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Motivational Abilities (EEfRT Task)
Motivational abilities evaluated using the Effort Expenditure for Rewards Task (EEfRT) on a cycle ergometer.
Time frame: Baseline, 6 weeks, 12 weeks, and 14 weeks.
Plan to share: No
Started Oct 2024 (actual). Primary completion is estimated for Oct 2027, 36 months after the start.
Of 472 non-industry interventional studies with no phase under Alcoholism, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 54. This study's planned 36 months is close to that.
Counting every sponsor, half of 495 studies reached it within 33 months; a quarter within 17 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire de Besancon →